A Facebook Group Led Him to Sell His Life Insurance Policy in a Multibillion-Dollar Market

Frank Sierawski got a diagnosis over a decade ago that most people never recover from: Stage IV lung cancer, a rare form, with a five-year survival rate around 20%, according to NPR's Planet Money. He was 35. He had a wife and three kids. He set a goal of living seven years.

He beat it. A new drug put his cancer into remission, and Sierawski is now 47. He kept paying premiums on two life insurance policies he'd taken out before his diagnosis, expecting nothing more than the standard deal: pay in while alive, family collects when you die.

Then, according to Planet Money, Sierawski was scrolling a Facebook group for cancer survivors about a year ago and found something that changed how he saw his own policy. It's called a life settlement. You sell your life insurance policy, while you're still alive, to an investor. The investor pays you a lump sum, usually 20 to 30 cents on the dollar of the policy's face value. From then on, the investor pays your premiums. When you die, the investor collects the full payout instead of your family.

"It's an asset I didn't know I had," Sierawski told Planet Money. "Which was like, whoa, mind-blowing."

He also figured out something else fast, because he described himself as a finance guy: these buyers make their best returns when the seller dies soon after the deal closes. So a cancer history, ironically, might make his policy more attractive, not less. He filled out some online forms. His phone started ringing off the hook, according to Planet Money's reporting.

Where this market actually came from

This isn't a new scheme dreamed up by hedge funds. Planet Money's reporting traces the origins of life settlements to the AIDS crisis in the 1980s, when men dying of AIDS, often young, often with no other assets, started making informal handshake deals to sell their life insurance policies for cash to cover medical bills and living expenses while they were still alive. There was no formal market, no standardized contracts, no real regulation. Just desperate people and buyers willing to bet on how long they had left.

Over decades, that informal practice grew into a formal, regulated financial industry. Today, life settlements represent a multibillion-dollar market, according to Planet Money, with institutional investors, brokers, and underwriters involved in pricing and buying policies from people who no longer want or need them, or who need cash now more than a payout later.

The uncomfortable math nobody hides

When an investor buys your policy, they are underwriting your remaining lifespan. A shorter life expectancy means a faster return on investment. A seller with a terminal diagnosis and a shortened prognosis is, from a pure investment standpoint, a better bet than a healthy 40-year-old.

Sierawski understood this, and it's part of why he went looking for a deal in the first place. He wasn't naive about it. He went into the negotiation knowing his cancer history was leverage, not a liability, in this specific transaction, according to Planet Money.

The case for the market, and the case against it

Supporters of life settlements make a straightforward argument: this is somebody's own property, and they should be free to sell it if they choose. If a policyholder decides cash today is worth more to them than a payout their family collects after death, that's a personal financial decision, not something the government or an insurer should block. Sierawski's own situation illustrates the case: he had two policies he no longer strictly needed given his changed circumstances, and a life settlement gave him liquidity while he was alive to actually use it.

The counterargument, which Planet Money's original reporting doesn't shy away from, is that a market built on speculating about when strangers will die is inherently unsettling. The AIDS-era origins of this practice, where dying men sold policies out of financial desperation rather than genuine choice, raise questions about whether sellers today, especially those facing serious illness, are negotiating from a position of real strength or just less-bad options.

Both things can be true. The transactions are legal, disclosed, and regulated by state insurance departments in the U.S. And the entire premise of the industry is that someone's mortality is the asset being traded.

What's unresolved

Planet Money's reporting doesn't specify what final offer Sierawski received or what he decided to do with his policies. It also doesn't detail how state regulators currently police pricing fairness or disclosure standards across this market as it's grown from AIDS-era handshake deals into an institutional asset class. Those specifics, how much sellers like Sierawski actually get compared to what investors eventually collect, and what oversight exists to make sure sick and dying people aren't underpaid for what they're selling, remain the open questions this story raises but doesn't answer.